Ac Immune Sa
AC Immune SA is a clinical-stage biotech targeting neurodegenerative diseases. Its SupraAntigen and Morphomer platforms generate antibodies and vaccines with assets like Crenezumab (Phase II AD) and ACI‑24 (Phase II Down syndrome‑AD). Partners include Genentech, Biogen and Lilly
Headquarters: Switzerland (CHE)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 133
- HQ: Lausanne
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.